Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Detection of antibodies specific for sheeppox and goatpox viruses using recombinant capripoxvirus antigens in an indirect enzyme-linked immunosorbent assay.

Bowden TR, Coupar BE, Babiuk SL, White JR, Boyd V, Duch CJ, Shiell BJ, Ueda N, Parkyn GR, Copps JS, Boyle DB.

J Virol Methods. 2009 Oct;161(1):19-29. doi: 10.1016/j.jviromet.2009.04.031. Epub 2009 May 6.

PMID:
19426763
2.

Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.

De Rose R, Batten CJ, Smith MZ, Fernandez CS, Peut V, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Venturi V, Davenport MP, Kent SJ.

J Virol. 2007 Jan;81(1):292-300. Epub 2006 Oct 18.

3.

4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.

Harrison JM, Bertram EM, Boyle DB, Coupar BE, Ranasinghe C, Ramshaw IA.

Vaccine. 2006 Nov 17;24(47-48):6867-74. Epub 2006 Jun 22.

PMID:
17050052
4.

Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.

Ranasinghe C, Medveczky JC, Woltring D, Gao K, Thomson S, Coupar BE, Boyle DB, Ramsay AJ, Ramshaw IA.

Vaccine. 2006 Jul 26;24(31-32):5881-95. Epub 2006 May 2.

PMID:
16759767
5.

Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.

Coupar BE, Purcell DF, Thomson SA, Ramshaw IA, Kent SJ, Boyle DB.

Vaccine. 2006 Feb 27;24(9):1378-88. Epub 2005 Oct 5.

PMID:
16257479
6.

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.

Kent SJ, Dale CJ, Ranasinghe C, Stratov I, De Rose R, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Wilson KM, Ramsay AJ.

Vaccine. 2005 Oct 10;23(42):5009-21.

PMID:
15985317
7.

Identification of a Bohle iridovirus thymidine kinase gene and demonstration of activity using vaccinia virus.

Coupar BE, Goldie SG, Hyatt AD, Pallister JA.

Arch Virol. 2005 Sep;150(9):1797-812. Epub 2005 May 11.

PMID:
15883656
8.

Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.

De Rose R, Chea S, Dale CJ, Reece J, Fernandez CS, Wilson KM, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Sullivan MT, Kent SJ.

Vaccine. 2005 Mar 14;23(16):1949-56.

PMID:
15734067
9.

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus.

Dale CJ, De Rose R, Stratov I, Chea S, Montefiori DC, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Law M, Kent SJ.

J Virol. 2004 Dec;78(24):13819-28.

10.

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNgamma or IL-12.

Dale CJ, De Rose R, Wilson KM, Croom HA, Thomson S, Coupar BE, Ramsay A, Purcell DF, Ffrench R, Law M, Emery S, Cooper DA, Ramshaw IA, Boyle DB, Kent SJ; Australian Thai HIV Vaccine Consortium.

Vaccine. 2004 Nov 25;23(2):188-97.

PMID:
15531036
11.

Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules.

Boyle DB, Anderson MA, Amos R, Voysey R, Coupar BE.

Biotechniques. 2004 Jul;37(1):104-6, 108-11.

12.

First identification of a ranavirus from green pythons (Chondropython viridis).

Hyatt AD, Williamson M, Coupar BE, Middleton D, Hengstberger SG, Gould AR, Selleck P, Wise TG, Kattenbelt J, Cunningham AA, Lee J.

J Wildl Dis. 2002 Apr;38(2):239-52.

PMID:
12038121
13.

A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever.

Hammond JM, Jansen ES, Morrissy CJ, Goff WV, Meehan GC, Williamson MM, Lenghaus C, Sproat KW, Andrew ME, Coupar BE, Johnson MA.

Vet Microbiol. 2001 May 21;80(2):101-19.

PMID:
11295331
14.

Rapid dissemination of intramuscularly inoculated DNA vaccines.

Mena A, Andrew ME, Coupar BE.

Immunol Cell Biol. 2001 Feb;79(1):87-9.

PMID:
11168628
15.

Comparative studies of piscine and amphibian iridoviruses.

Hyatt AD, Gould AR, Zupanovic Z, Cunningham AA, Hengstberger S, Whittington RJ, Kattenbelt J, Coupar BE.

Arch Virol. 2000;145(2):301-31.

PMID:
10752555
16.

The immune response to a polyoma virus replicon-based DNA vaccine.

Mena A, Coupar BE, Andrew ME.

Vaccine. 2000 Aug 15;19(1):68-74.

PMID:
10924788
17.

Protection of pigs against classical swine fever with DNA-delivered gp55.

Andrew ME, Morrissy CJ, Lenghaus C, Oke PG, Sproat KW, Hodgson AL, Johnson MA, Coupar BE.

Vaccine. 2000 Mar 17;18(18):1932-8.

PMID:
10699343
18.

Insertion sites for recombinant vaccinia virus construction: effects on expression of a foreign protein.

Coupar BE, Oke PG, Andrew ME.

J Gen Virol. 2000 Feb;81(Pt 2):431-9.

PMID:
10644842
19.

The ovine cytotoxic T lymphocyte responses to bluetongue virus.

Janardhana V, Andrew ME, Lobato ZI, Coupar BE.

Res Vet Sci. 1999 Dec;67(3):213-21.

PMID:
10607500
20.

Expression of the potyvirus coat protein mediated by recombinant vaccinia virus and assembly of potyvirus-like particles in mammalian cells.

Hammond JM, Sproat KW, Wise TG, Hyatt AD, Jagadish MN, Coupar BE.

Arch Virol. 1998;143(7):1433-9.

PMID:
9722886
22.

Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

Lobato ZI, Coupar BE, Gray CP, Lunt R, Andrew ME.

Vet Immunol Immunopathol. 1997 Nov;59(3-4):293-309.

PMID:
9477479
23.
24.

A synthetic vaccinia virus promoter with enhanced early and late activity.

Hammond JM, Oke PG, Coupar BE.

J Virol Methods. 1997 Jun;66(1):135-8.

PMID:
9220399
25.

Comparison of field and vaccine strains of Australian fowlpox viruses.

Boyle DB, Pye AD, Coupar BE.

Arch Virol. 1997;142(4):737-48.

PMID:
9170501
26.

Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.

Thomson SA, Elliott SL, Sherritt MA, Sproat KW, Coupar BE, Scalzo AA, Forbes CA, Ladhams AM, Mo XY, Tripp RA, Doherty PC, Moss DJ, Suhrbier A.

J Immunol. 1996 Jul 15;157(2):822-6.

PMID:
8752934
27.

Production and characterisation of ovine GM-CSF expressed in mammalian and bacterial cells.

O'Brien PM, Seow HF, Entrican G, Coupar BE, Wood PR.

Vet Immunol Immunopathol. 1995 Oct;48(3-4):287-98.

PMID:
8578687
28.

Induction of rotavirus-specific cytotoxic T lymphocytes by vaccinia virus recombinants expressing individual rotavirus genes.

Offit PA, Coupar BE, Svoboda YM, Jenkins RJ, McCrae MA, Abraham A, Hill NL, Boyle DB, Andrew ME, Both GW.

Virology. 1994 Jan;198(1):10-6.

PMID:
8259644
29.

Rotavirus VP6 modified for expression on the plasma membrane forms arrays and exhibits enhanced immunogenicity.

Reddy DA, Bergmann CC, Meyer JC, Berriman J, Both GW, Coupar BE, Boyle DB, Andrew ME, Bellamy AR.

Virology. 1992 Aug;189(2):423-34.

PMID:
1322583
30.

Biological effects of recombinant vaccinia virus-expressed interleukin 4.

Andrew ME, Coupar BE.

Cytokine. 1992 Jul;4(4):281-6. Erratum in: Cytokine 1993 Jan;5(1):89.

PMID:
1515552
31.

Relocation of antigens to the cell surface membrane can enhance immune stimulation and protection.

Both GW, Andrew ME, Boyle DB, Coupar BE, Bellamy AR.

Immunol Cell Biol. 1992 Feb;70 ( Pt 1):73-8.

PMID:
1322362
32.

Vaccinia-rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea.

Andrew ME, Boyle DB, Coupar BE, Reddy D, Bellamy AR, Both GW.

Vaccine. 1992;10(3):185-91.

PMID:
1313627
33.

Effects of vaccinia virus-expressed interleukin 2 on the immune system of sublethally irradiated mice.

Andrew ME, Karupiah G, Boyle DB, Blanden RV, Mullbacher A, Ramshaw IA, Coupar BE.

Microb Pathog. 1991 May;10(5):363-71.

PMID:
1753876
34.
35.

Restriction endonuclease mapping of the fowlpox virus genome.

Coupar BE, Teo T, Boyle DB.

Virology. 1990 Nov;179(1):159-67.

PMID:
2171203
36.

Vaccinia virus expression and sequence of an avian influenza nucleoprotein gene: potential use in diagnosis.

Harley VR, Hudson PJ, Coupar BE, Selleck PW, Westbury H, Boyle DB.

Arch Virol. 1990;113(1-2):133-41.

PMID:
2386434
37.

Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.

Karupiah G, Coupar BE, Andrew ME, Boyle DB, Phillips SM, Müllbacher A, Blanden RV, Ramshaw IA.

J Immunol. 1990 Jan 1;144(1):290-8.

PMID:
2295796
38.

Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice.

Andrew ME, Coupar BE, Boyle DB.

Immunol Cell Biol. 1989 Oct;67 ( Pt 5):331-7.

PMID:
2613280
39.

Recombinant vaccinia viruses and the development of immunization strategies using influenza virus.

Doherty PC, Allan W, Boyle DB, Coupar BE, Andrew ME.

J Infect Dis. 1989 Jun;159(6):1119-22. No abstract available.

PMID:
2786041
41.
42.
43.

Construction of recombinant fowlpox viruses as vectors for poultry vaccines.

Boyle DB, Coupar BE.

Virus Res. 1988 Jun;10(4):343-56.

PMID:
2842977
44.

A dominant selectable marker for the construction of recombinant poxviruses.

Boyle DB, Coupar BE.

Gene. 1988 May 15;65(1):123-8.

PMID:
2840353
45.

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.

Ramshaw IA, Andrew ME, Phillips SM, Boyle DB, Coupar BE.

Nature. 1987 Oct 8-14;329(6139):545-6.

PMID:
3498904
46.
48.

Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies.

Andrew ME, Boyle DB, Coupar BE, Whitfeld PL, Both GW, Bellamy AR.

J Virol. 1987 Apr;61(4):1054-60.

49.

Fowlpox virus thymidine kinase: nucleotide sequence and relationships to other thymidine kinases.

Boyle DB, Coupar BE, Gibbs AJ, Seigman LJ, Both GW.

Virology. 1987 Feb;156(2):355-65.

PMID:
3027984
50.

The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.

Andrew ME, Coupar BE, Boyle DB, Ada GL.

Scand J Immunol. 1987 Jan;25(1):21-8.

PMID:
3492756

Supplemental Content

Loading ...
Support Center